Sellas Life Sciences Group Inc (SLS)
Retained Earnings
-$293.00M
Quarterly · Period ending: · USD
SLS Retained Earnings
Latest reported-$293.00Mperiod ending
Latest reported-$293.00Mperiod ending
SLS Quarterly Retained Earnings ($0.00 → -$293.00M)
Quarterly retained earnings
High-resolution chart · PNG
SLS retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -293,000,000 | |
| -283,395,000 | |
| -274,988,000 | |
| -267,330,000 | |
| -260,539,000 | |
| -253,938,000 | |
| -248,125,000 | |
| -241,388,000 | |
| -234,280,000 | |
| -226,810,000 | |
| -217,244,000 | |
| -209,108,000 | |
| -199,841,000 | |
| -191,001,000 | |
| -179,904,000 | |
| -170,783,000 | |
| -163,761,000 | |
| -155,347,000 | |
| -138,603,000 | |
| -132,005,000 | |
| -124,920,000 | |
| -120,307,000 | |
| -117,904,000 | |
| -114,188,000 | |
| -109,715,000 | |
| -105,290,000 | |
| -101,147,000 | |
| -93,728,000 | |
| -89,526,000 | |
| -86,392,000 | |
| -81,855,000 | |
| -68,532,000 | |
| -68,242,000 | |
| -62,180,000 | |
| -54,185,000 | |
| -329,129,000 | |
| -323,054,000 | |
| -314,650,000 | |
| -302,932,000 | |
| -297,416,000 | |
| -290,487,000 | |
| -295,876,000 | |
| -279,383,000 | |
| -259,705,000 | |
| -241,678,000 | |
| -226,018,000 | |
| -215,481,000 | |
| -207,525,000 | |
| -201,352,000 | |
| -181,411,000 | |
| -178,875,000 | |
| -130,374,000 | |
| -121,087,000 | |
| -111,490,000 | |
| -102,197,000 | |
| -98,446,000 | |
| -92,185,000 | |
| -91,989,000 | |
| -67,228,000 | |
| -68,817,000 | |
| -60,970,000 | |
| -59,585,000 | |
| -55,743,000 | |
| -53,912,000 | |
| -49,777,000 | |
| -47,636,000 | |
| -43,750,000 | |
| -37,602,000 | |
| -34,615,000 | |
| -29,534,000 | |
| -25,363,000 | |
| -21,362,000 | |
| -17,954,000 | |
| -13,636,000 | |
| -10,990,000 | |
| -8,367,000 | |
| 0 |